JMP Securities analyst David Turkaly reiterated a Buy rating on Steris (NYSE:STE) plc on Friday, setting a price target of $250, which is approximately 16.27% above the present share price of $215.01.
Turkaly expects Steris plc to post earnings per share (EPS) of $1.02 for the third quarter of 2021.
The current consensus among 3 TipRanks analysts is for a Strong Buy rating of shares in Steris, with an average price target of $237.67.
The analysts price targets range from a high of $250 to a low of $230.
In its latest earnings report, released on 03/31/2021, the company reported a quarterly revenue of $873.53 million and a net profit of $143.05 million. The company's market cap is $21.43 billion.
According to TipRanks.com, JMP Securities analyst David Turkaly is currently ranked with 4 stars on a 0-5 stars ranking scale, with an average return of 13.2% and a 53.15% success rate.
STERIS Plc (Ireland) engages in the manufacture of medical and surgical equipment. The company was founded on December 22, 2016 and is headquartered in Dublin, Ireland.